Pharmaceutical industry
The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society of Chemistry's magazine, Chemistry World
-
FeatureThe curious case of disappearing polymorphs
From crystallographers’ beards to billion-dollar lawsuits, the phenomenon of disappearing polymorphs has puzzled chemists for decades. Now researchers are finally unravelling the science behind why stable crystal forms suddenly vanish – and discovering how to bring them back
-
OpinionIndia’s generic semaglutide surge
As patents on Novo Nordisk’s diabetes and weight loss blockbusters expire, generic makers have their versions ready
-
BusinessHow to choose reactor materials and test for compatibility
Merck & Co team describes simple testing strategies and criteria for decision-making
-
Opinion‘The truth is supremely valuable and we cannot lie our way to it’
As a scientist with family in Iran, Derek Lowe finds his own government’s approach to truth alarming
-
BusinessBoron plays a key role in new sleeping sickness drug
Acoziborole is the first single-dose treatment for both early and late stage sleeping sickness
-
WebinarTaking the sting out of pain: how marine venoms can be used to heal
Join us on 24 April to learn how marine venoms are being used to treat chronic pain
-
OpinionModerna’s vaccine regulatory hokey-cokey
US FDA initially refused to accept flu vaccine for review, but has since reversed that decision
-
WebinarHigh‑throughput retrosynthesis for real‑world chemistry
Discover how retrosynthesis software, paired with application programming interfaces, can accelerate route design, virtual screening and practical synthesis decisions
-
OpinionSlimming down competition over weight-loss drugs
Legal battle between Novo Nordisk and US compounding pharmacy Hims & Hers has fizzled after regulator intervention
-
ResearchWorld first for clinical trial of skin patch to monitor therapeutic drugs in real time
Sensor could soon help doctors to prevent overdoses of drugs
-
OpinionIs it cold in here?
Labs in Delhi, Aberdeen and Arizona will have different ideas of ‘room temperature’
-
NewsIn 2023, the UK was the first country to approve a Crispr therapy. How’s it doing?
Disconnect exists between the media hype around gene-editing treatment and the reality for patients
-
OpinionTrump’s attack on science is shaking industry’s foundations
By dismantling scientific enterprise, the US risks ‘taking a hammer to our miracle machine’
-
-
OpinionA unifying force for African medicines
The new African Medicines Agency is hugely important but faces significant challenges
-
OpinionLearning computational chemistry in a new role
A change of team brings new opportunities to build knowledge
-
BusinessUK agrees higher drug prices to secure zero-tariff deal with US
NHS could pay up to 25% more for innovative drugs, but exports will be tariff free for three years
-
OpinionWhat’s on your lab technology wish list?
Once-magical tools are now mundane. What will the next miracles be?
-
OpinionInhaler propellant switch is worth the effort
Memories of a year spent testing new inhaler valve designs
-
NewsCould Crispr cure HIV?
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at evading eradication